Framework for preliminary risk assessment of brownfield sites von Mahammedi, C., Mahdjoubi, L., Booth, C.A., Butt, T.E.

Volltext

A systematic review of risk assessment tools for contaminated sites – Current perspectives and future prospects von Mahammedi, C., Mahdjoubi, L., Booth, C.A., Akram, H., Butt, T.E.

Volltext

Une ataxie cérébelleuse par carence en acide folique révélant une maladie coeliaque von Maamar, S., Benlazar, S.M., Mahammedi, C.

Volltext

Une gonarthrite trompeuse d’origine mixte : rhumatoïde et hydatique von Maamar, S., Tabeti, M., Mahammedi, C.

Volltext

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multic... von Kwon, Eugene D, Prof, Drake, Charles G, MD, Scher, Howard I, Prof, Fizazi, Karim, Prof, Bossi, Alberto, MD, van den Eertwegh, Alfons J M, MD, Krainer, Michael, MD, Houede, Nadine, MD, Santos, Ricardo, MD, Mahammedi, Hakim, MD, Ng, Siobhan, MD, Maio, Michele, MD, Franke, Fabio A, MD, Sundar, Santhanam, MBBS, Agarwal, Neeraj, MD, Bergman, Andries M, MD, Ciuleanu, Tudor E, Prof, Korbenfeld, Ernesto, MD, Sengeløv, Lisa, MD, Hansen, Steinbjorn, MD, Logothetis, Christopher, Prof, Beer, Tomasz M, Prof, McHenry, M Brent, PhD, Gagnier, Paul, MD, Liu, David, MD, Gerritsen, Winald R, Prof

Volltext

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer von Fizazi, Karim, Shore, Neal, Tammela, Teuvo L, Ulys, Albertas, Vjaters, Egils, Polyakov, Sergey, Jievaltas, Mindaugas, Luz, Murilo, Alekseev, Boris, Kuss, Iris, Kappeler, Christian, Snapir, Amir, Sarapohja, Toni, Smith, Matthew R

Volltext

A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Pa... von Colomba, Emeline, Jonas, Sarah Flora, Eymard, Jean-Christophe, Delva, Rémi, Brachet, Pierre Emmanuel, Neuzillet, Yann, Penel, Nicolas, Roubaud, Guilhem, Bompas, Emmanuelle, Mahammedi, Hakim, Longo, Raffaelle, Helissey, Carole, Barthélemy, Philippe, Borchiellini, Delphine, Hasbini, Ali, Priou, Franck, Saldana, Carolina, Voog, Eric, Narcisso, Bérangère, Ladoire, Sylvain, Berdah, Jean-François, Aisenfarb, Jean-Baptiste, Foulon, Stéphanie, Fizazi, Karim

Volltext

Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial von Fizazi, Karim, Retz, Margitta, Petrylak, Daniel P, Goh, Jeffrey C, Perez-Gracia, Jose, Lacombe, Louis, Zschäbitz, Stefanie, Burotto, Mauricio, Mahammedi, Hakim, Gravis, Gwenaelle, Bastos, Diogo Assed, McCune, Steven L, Vázquez Limón, Juan Carlos, Kwan, Edmond M, Castellano, Daniel, Fléchon, Aude, Saad, Fred, Grimm, Marc-Oliver, Shaffer, David R, Armstrong, Andrew J, Bhagavatheeswaran, Prabhu, Amin, Neha P, Ünsal-Kaçmaz, Keziban, Wang, Xuya, Li, Jun, Loehr, Andrea, Pachynski, Russell K

Volltext

Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial von Flippot, R., Dalban, C., Laguerre, B., Borchiellini, D., Gravis, G., Negrier, S., Chevreau, C.M., Joly, F., Geoffrois, L., Ladoire, S., Mahammedi, H., Tantot, F., Escudier, B., Albiges, L.

Volltext

1977P Efficacy of talazoparib and avelumab as a maintenance treatment in patients with advanced/metastatic urothelial carcinoma (mUC) whose disease did not progress after a first-l... von Coquan, E., Boughalem, E., Pouessel, D., Lequesne, J., Calcagno, F., Grellard, J-M., Christy, F., Mahammedi, H., Ladoire, S., Borchiellini, D., Leman, R., Bazille, C., Fontugne, J., Crouzet, L., Flechon, A., Serrate, C., Gravis, G., Clarisse, B., Thiery Vuillemin, A., Joly Lobbedez, F.

Volltext

652O Dose-dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as perioperative chemotherapy for patients with muscle-invasive bla... von Pfister, C., Gravis, G., Flechon, A., Chevreau, C.M., Mahammedi, H., Laguerre, B., Guillot, A., Joly, F., Soulie, M., Allory, Y., Harter, V., Culine, S.

Volltext

603P Objective computerized cognitive assessment in men with metastatic castrate-resistant prostate cancer (mCRPC) randomly receiving darolutamide or enzalutamide in the ODENZA tri... von Colomba, E., Jonas, S.F., Eymard, J-C., Delva, R., Brachet, P.E., Neuzillet, Y., Penel, N., Roubaud, G., Bompas, E., Mahammedi, H., Longo, R., Helissey, C., Barthelemy, P., Borchiellini, D., Hasbini, A., Priou, F., Saldana, C., Voog, E., Foulon, S., Fizazi, K.

Volltext

712P Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial von Courcier, J., Dalban, C., Laguerre, B., Ladoire, S., Barthélémy, P., Oudard, S., Joly, F., Gravis Mescam, G., Chevreau, C.M., Geoffrois, L., Deluche, E., Rolland, F., Topart, D., Culine, S., Négrier, S., Mahammedi, H., Tantot, F., Escudier, B., Flippot, R., Albiges, L.

Volltext

715P Nivolumab in pretreated metastatic penile squamous cell carcinoma: Results of the penile cohort from the French AcSé prospective program von Pouessel, D., Beylot-Barry, M., Esma, S.B., De Pontville, M., Coquan, E., Mahammedi, H., Gavoille, C., Ghiringhelli, F., Dereure, O., Spano, J-P., Tosi, D., Fléchon, A., Pannier, D., Augereau, P., Gambotti, L., Legrand, F., Simon, C., Lamrani-Ghaouti, A., Chevret, S., Marabelle, A.

Volltext

Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer von Mbatchi, Litaty C., Gassiot, Matthieu, Pourquier, Philippe, Goberna, Alejando, Mahammedi, Hakim, Mourey, Loic, Joly, Florence, Lumbroso, Serge, Evrard, Alexandre, Houede, Nadine

Volltext

2594 Safety and efficacy of Temsirolimus (Torisel®) as second line treatment for patients with recurrent bladder cancer von Houede, N, Roubaud, G, Mahammedi, H, Vedrine, L, Joly, F, Mourey, L, Pfister, C, Culine, S, Goberna, A, Lortal, B, Pulido, M, Pourquier, P, Bellera, C

Volltext

P181 WITNESS: Real-world outcomes of Nivolumab (NIVO) + Ipilimumab (IPI) in patients (pts) with previously untreated clear cell advanced Renal Cell Carcinoma (aRCC) in France - 1 y... von Barthélémy, P., Vano, Y-A., Eymard, J-C., Narciso, B., Martin, S., Bigot, P., Chehimi, M., Bennamoun, M., Mouillet, G., Moreira, A., Solub, D., L Haridon, T., Gimel, P., Mahammedi, H., Thiery-Vuillemin, A., Petit, G., Escudier, B., Albigès, L.

Volltext

868PDBrain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial von Flippot, R, Dalban, C, Laguerre, B, Borchiellini, D, Gravis, G, Negrier, S, Chevreau, C M, Joly, F, Geoffrois, L, Ladoire, S, Mahammedi, H, Tantot, F, Escudier, B, Albiges, L

Volltext

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative c... von Pfister, Christian, Harter, Valentin, Allory, Yves, Radvanyi, François, Culine, Stéphane, Grawis, G., Pignot, G., Flechon, A., Fendler, J.P., Chevreau, C., Soulie, M., Mahammedi, H., Guy, L., Laguerre, B., Verhoest, G., Guillot, A., Mottet, N., Joly, F., Doerfler, A., Abadie-Lacourtoisie, S., Azzouzi, A.R., Mongiat, P., Geoffrois, L., Eschwege, P., Di Fiore, F., Roubaud, G., Hoepffner, J.L., Barthelemy, P., Lang, H., Voog, E., Mandron, E., Tourani, J.M., Serrrate, C., Colau, A., Saldana, C., de La Taille, A., Nguyen, T., Kleinclauss, F., Loriot, Y., Irani, J., Eymard, J.C., Larre, S., Huillard, O., Zerbib, M., Rolland, F., Rigaud, J., Houede, N., Droupy, S., Malouf, G., Roupret, M., El Demery, M., Legon, C., Vieillot, S., Letang, N., Lharidon, T., Gaschignard, N., Hilgers, W., Davin, J.L.

Volltext

Denosumab in patients with bone metastases from renal-cell carcinoma treated with anti-angiogenic therapy: a retrospective study from the GETUG (Groupe Etude des Tumeurs Uro Genita... von Guillot, A., Joly, C., Barthelemy, P., Meriaux, E., Negrier, S., Pouessel, D., Chevreau, C., Mahammedi, H., Houede, N., Roubaud, G., Gravis, G., Tartas, S., Albiges, L., Vassal, C., Oriol, M., Tinquaut, F., Espenel, S., Culine, S., Fizazi, K.

Volltext